Exhibiting at Fi South America 2025

Guangdong VTR Bio-Tech Co., Ltd. is a leading biotechnology enterprise headquartered in Zhuhai, Guangdong, China. Established in 1991, the company has emerged as one of the most influential bio-enzyme and biomanufacturing companies in Asia, driving innovation in enzyme technology and green biosolutions for a wide range of industries. VTR is publicly listed on the Shenzhen Stock Exchange under the ticker symbol 300381.SZ. ## Core Business VTR Bio-Tech specializes in the research, development, production, and marketing of bio-enzymes and biological solutions. With a strong commitment to sustainable development, VTR develops enzymes that enable environmentally friendly, cost-effective alternatives to traditional chemical processes across industries such as food & beverage, textiles, animal nutrition, pharmaceuticals, biofuels, and detergents. ## Product and Service Offerings VTR’s comprehensive product portfolio includes over 400 enzyme formulations, serving diverse application sectors: - Food & Beverage: - Amylase, protease, and xylanase enzymes for starch processing, brewing, and baking. - Enzymes for juice clarification and flavor enhancement. - Animal Nutrition & Health: - Feed enzymes like phytase, xylanase, and beta-mannanase to improve nutrient absorption and reduce emissions. - Biofuel: - Enzymatic solutions for biomass conversion, including cellulases and hemicellulases. - Detergents: - Proteases, lipases, and amylases optimized for low-temperature washing. - Textiles and Leather: - Enzymes for bio-polishing, desizing, and degumming. - Pulp & Paper: - Enzymes for fiber modification, deinking, and bleaching to reduce chemical usage. - Plant Extracts and Pharmaceuticals: - Enzymes used in high-efficiency extraction and synthesis processes. The company’s enzyme brands include Vnzymes, which cater to high-end industrial clients seeking high-performance biosolutions. ## Specialization and Unique Strengths VTR stands out due to its vertically integrated operations—from gene mining and strain development to fermentation, formulation, and application support. The company operates one of the largest fermentation facilities in China and has over 600 patents, including invention patents in China, the U.S., and Europe. Its R&D infrastructure includes: - National Postdoctoral Research Station - Guangdong Provincial Engineering Research Center for Industrial Enzymes - Joint research laboratories with over 20 universities and institutes With a focus on synthetic biology, VTR is transitioning toward next-generation precision fermentation and CRISPR-based strain engineering, aiming to enhance enzyme yields and functionalities. ## Financials As a listed company, VTR Bio-Tech has demonstrated solid financial performance: - Revenue (2023): ¥1.86 billion (~USD 255 million) - Net Profit (2023): ¥305 million (~USD 42 million) - R&D Investment (2023): ~6.3% of total revenue - Market Cap (August 2025): Approx. ¥6.2 billion (~USD 850 million) The company’s consistent profitability is driven by high-margin enzyme products and long-term supply contracts with global food and industrial giants. ## Shipments and Global Footprint While VTR primarily manufactures in China, its products are exported to over 50 countries, including key markets in Southeast Asia, South America, Europe, and the Middle East. According to third-party trade intelligence sources: - Export Volume (2022–2024): Over 12,000 metric tons of enzyme products shipped internationally. - Export Value: Estimated over USD 170 million in cumulative trade value over 3 years. - Top Export Destinations: Brazil, India, Thailand, Egypt, Indonesia, Germany. The company holds partnerships with global distributors and collaborates with multinational firms for custom enzymatic solutions. ## Target Markets - Industrial food and beverage producers - Animal feed and nutrition companies - Detergent and household care product manufacturers - Textile and paper processing industries - Biofuel and green chemical manufacturers - Pharmaceutical companies seeking biocatalysis and green extraction processes ## Capabilities - Annual enzyme production capacity: Over 25,000 metric tons - Production Sites: Zhuhai (headquarters), Hunan, and Inner Mongolia - R&D Staff: Over 350 researchers, including 50+ PhDs - Regulatory Compliance: GMP, ISO 9001, ISO 14001, FAMI-QS, and HALAL-certified production lines ## Certifications and Compliance - FAMI-QS: Ensures feed additive quality and safety compliance in the EU - ISO 9001 / ISO 14001: Quality and environmental management standards - Kosher and Halal certifications for enzyme ingredients - GMP Certification for pharmaceutical-related enzyme production - REACH Pre-registration for products exported to the EU ## Customer Testimonials > "VTR's enzymes have significantly improved our product yields while reducing processing time. Their technical team offers exceptional support and customization." > — R&D Manager, Global Brewery Group > "Switching to VTR's enzyme blends helped us cut detergent formulation costs by 18% while enhancing performance. Their expertise in formulation science is unmatched." > — Head of Innovation, Household Care Company, India ## Major Achievements - First Chinese biotech company to receive National Technological Invention Award in the enzyme field - Recognized as one of China’s Top 100 Innovative Enterprises by Ministry of Industry and Information Technology - Built one of Asia's largest high-efficiency fermentation centers (20,000m²) - Played a critical role in China's push for green manufacturing and low-carbon bioprocessing via government-industry partnerships